4//SEC Filing
White Karen Ann 4
Accession 0001209191-23-041212
CIK 0001818331other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 5:18 PM ET
Size
9.4 KB
Accession
0001209191-23-041212
Insider Transaction Report
Form 4
White Karen Ann
Chief People Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2023-07-01+99→ 4,730 total - Exercise/Conversion
Restricted Stock Unit
2023-07-01−99→ 1,092 total→ Class A Common Stock (99 underlying) - Sale
Class A Common Stock
2023-07-03$5.99/sh−45$270→ 4,685 total
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
- [F2]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F3]6.25% vest in quarterly installments over the 4-year period commencing on April 4, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date
Documents
Issuer
GeneDx Holdings Corp.
CIK 0001818331
Entity typeother
Related Parties
1- filerCIK 0001874118
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 5:18 PM ET
- Size
- 9.4 KB